TY  - RPRT
TI  - Vulnerabilities of the SARS-CoV-2 virus to proteotoxicity -- opportunity for repurposed chemotherapy of COVID-19 infection
AU  - Al-Motawa, M.
AU  - Abbas, H.
AU  - Wijten, P.
AU  - de la Fuente, A.
AU  - Xue, M.
AU  - Rabbani, N.
AU  - Thornalley, P.
PY  - 2020
DO  - 10.1101/2020.04.07.029488
UR  - https://www.biorxiv.org/content/10.1101/2020.04.07.029488v1
ID  - 10.1101/2020.04.07.029488
ER  -